US Patent Issued to Janssen Pharmaceuticals on Aug. 18 for "Bi- and monocyclic nucleoside analogs for treatment of hepatitis E" (Belgian Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,641, issued on Aug. 18, was assigned to Janssen Pharmaceuticals Inc. (Titusville, N.J.).

"Bi- and monocyclic nucleoside analogs for treatment of hepatitis E" was invented by Tim Hugo Maria Jonckers (Heist-op-den-Berg, Belgium), Frederik Pauwels (Waasmunster, Belgium) and Yannick Debing (Bilzen, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed toward bi- and monocyclic nucleoside analogs, and compositions comprising these compounds for use in the treatment of hepatitis E infections."

The patent was filed on April 13, 2021, under Application No. 17/996,083.

*For further information, including images, charts a...